AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11049837 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg codeine
Number of subjects: 12
Study 11049837 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg naltrexone
Number of subjects: 12
Study 11049837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9274760 — intervention group
Group type: EXPERIMENTAL
Intervention: Binocular visual direction with adjacent binocular objects; specific intervention details such as dosage and duration are not available.
Number of subjects: 0
Study 9274760 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocular objects viewed in the presence of adjacent binocular objects; specific intervention details such as dosage and duration are not available.
Number of subjects: 0
Study 9274760 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonius lines as indicators of eye position; specific intervention details such as dosage and duration are not available.
Number of subjects: 0
Study 8453969 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (100 mg bid for 7 days)
Number of subjects: 15
Study 8453969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 3739581 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary dose of 20 ml mepivacaine 1% with adrenaline
Number of subjects: 233
Study 3739581 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementary dose)
Number of subjects: 233
Study 30753371 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0
Study 30753371 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25693011 — intervention group
Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Number of subjects: 14215
Study 25693011 — intervention group
Group type: COMPARATOR
Intervention: qHPV vaccine
Number of subjects: 14215
Study 22991337 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical pessary
Number of subjects: 243
Study 22991337 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Number of subjects: 243
Study 22991337 — intervention group
Group type: COMPARATOR
Intervention: Cerclage
Number of subjects: 243
Study 22090182 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal balloon angioplasty (PTA)
Number of subjects: 54
Study 22090182 — intervention group
Group type: COMPARATOR
Intervention: Primary stenting (balloon expandable stent)
Number of subjects: 54
Study 19531899 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin (2 mg/day)
Number of subjects: 160
Study 19531899 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 160
Study 16464810 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive pharmaceutical care campaign targeting inappropriate use of triptans
Number of subjects: 2463
Study 16464810 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 2463
Study 14725513 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (1mg x kg(‐1) bolus, followed by an infusion at 250 microg x kg(‐1)min(‐1))
Number of subjects: 60
Study 14725513 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.04 mg x kg(‐1))
Number of subjects: 60
Study 14725513 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 60
Study 11328905 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin (initial dose reduced to 50% if no clotting observed, approximately 5000 IU IV)
Number of subjects: 12
Study 11328905 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin treatment
Number of subjects: 12
Study 11328905 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 12
Study 11328905 — intervention group
Group type: COMPARATOR
Intervention: Control group (pre-dialytic patients)
Number of subjects: 12
Study 10495794 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine alone (monotherapy)
Number of subjects: 354
Study 10495794 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine plus steroids (double therapy)
Number of subjects: 354
Study 10495794 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine plus steroids plus azathioprine (triple therapy)
Number of subjects: 354
Study 10495794 — intervention group
Group type: EXPERIMENTAL
Intervention: Switched from monotherapy to double or triple therapy
Number of subjects: 354
Study 10495794 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 354
Study 10495794 — intervention group
Group type: COMPARATOR
Intervention: Double therapy
Number of subjects: 354
Study 10495794 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy
Number of subjects: 354
Study 7956701 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical mediastinal lymph node dissection (average 11.5 nodes dissected)
Number of subjects: 225
Study 7956701 — intervention group
Group type: COMPARATOR
Intervention: Control group (dissected only suspected metastatic lymph nodes, average 3.4 nodes)
Number of subjects: 225
Study 3802437 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural hypotension (Group 1)
Number of subjects: 0
Study 3802437 — intervention group
Group type: COMPARATOR
Intervention: Other groups (Group 2, 3, and 4)
Number of subjects: 0
Study 31841577 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acyclovir, 5 mg/kg, 3 times daily for 14 days
Number of subjects: 238
Study 31841577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study 29436401 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery (FLACS)
Number of subjects: 400
Study 29436401 — intervention group
Group type: COMPARATOR
Intervention: Conventional phacoemulsification surgery (CPS)
Number of subjects: 400
Study 29436401 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical 3:1 model
Number of subjects: 400
Study 29436401 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical 4:1 model
Number of subjects: 400
Study 26989818 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation and massage
Number of subjects: 105
Study 26989818 — intervention group
Group type: COMPARATOR
Intervention: Massage only (control)
Number of subjects: 105
Study 25082852 — intervention group
Group type: COMPARATOR
Intervention: No additional preparation (Group 1)
Number of subjects: 36
Study 25082852 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial high-fat solution containing 43.8 g of lipids (Group 2)
Number of subjects: 36
Study 25082852 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mL of olive oil (Group 3)
Number of subjects: 36
Study 25082852 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (Group 4)
Number of subjects: 36
Study 25082852 — intervention group
Group type: EXPERIMENTAL
Intervention: cFFA levels
Number of subjects: 36
Study 25082852 — intervention group
Group type: EXPERIMENTAL
Intervention: cFFA level (cutoff value)
Number of subjects: 36
Study 23259261 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal balancing intervention (acu-puncture and Tuina applied to specific points)
Number of subjects: 120
Study 23259261 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture (applied to local points and affected meridians)
Number of subjects: 120
Study 23259261 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal balancing intervention
Number of subjects: 120
Study 23259261 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 120
Study 21083721 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 69
Study 21083721 — intervention group
Group type: COMPARATOR
Intervention: Quiet rest
Number of subjects: 69
Study 18480694 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecamylamine hydrochloride (MEC) up to 10 mg/d; n = 11
Number of subjects: 21
Study 18480694 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLO); n = 10
Number of subjects: 21
Study 15746684 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal assessment of fetal head station using a birth simulator
Number of subjects: 57
Study 11210400 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin XL 15 mg (fed treatment)
Number of subjects: 0
Study 9611701 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE) only
Number of subjects: 596
Study 9611701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 596
Study 9611701 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE combined with progestins
Number of subjects: 596
Study 7801420 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oestrogen therapy (ethinyl oestradiol 1 mg daily for 2 weeks, then 150 micrograms; intramuscular polyoestradiol phosphate 160 mg monthly for 3 months, then 80 mg)
Number of subjects: 100
Study 7801420 — intervention group
Group type: COMPARATOR
Intervention: Surgical castration (orchidectomy)
Number of subjects: 100
Study 2971184 — intervention group
Group type: EXPERIMENTAL
Intervention: RU 41740
Number of subjects: 314
Study 2971184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study 29667290 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 850 mg thrice daily for 52 months
Number of subjects: 390
Study 29667290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 390
Study 27367242 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI-guided surgery
Number of subjects: 184
Study 27367242 — intervention group
Group type: COMPARATOR
Intervention: Standard microsurgery (control group)
Number of subjects: 184
Study 23266255 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% menthol inhalation
Number of subjects: 14
Study 23266255 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% menthol inhalation
Number of subjects: 14
Study 23266255 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline with 0.05% menthol)
Number of subjects: 14
Study 23266255 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 subjects)
Number of subjects: 14
Study 22256165 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 hour turning intervals
Number of subjects: 0
Study 22256165 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 hour turning intervals
Number of subjects: 0
Study 22256165 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 hour turning intervals
Number of subjects: 0
Study 22256165 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabor filter technique
Number of subjects: 0
Study 19166870 — intervention group
Group type: EXPERIMENTAL
Intervention: Verb primes located in a remote position
Number of subjects: 0
Study 19166870 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote primes
Number of subjects: 0
Study 19166870 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantic relations
Number of subjects: 0
Study 16723313 — intervention group
Group type: EXPERIMENTAL
Intervention: Object alternation task
Number of subjects: 29
Study 16723313 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial stimulus-response incompatibility task
Number of subjects: 29
Study 16723313 — intervention group
Group type: EXPERIMENTAL
Intervention: Gambling task
Number of subjects: 29
Study 16723313 — intervention group
Group type: EXPERIMENTAL
Intervention: Response times in object alternation task
Number of subjects: 29
Study 16723313 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 29
Study 14966713 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance rehabilitation with visual cue deprivation
Number of subjects: 20
Study 14966713 — intervention group
Group type: COMPARATOR
Intervention: Balance rehabilitation with free vision
Number of subjects: 20
Study 11305509 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxiglumide (10 mg/kg i.v.)
Number of subjects: 10
Study 11305509 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 11305509 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication
Number of subjects: 10
Study 11305509 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxiglumide in H. pylori-eradicated subjects
Number of subjects: 10
Study 9631991 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 450 mg once weekly for 4 months
Number of subjects: 384
Study 9631991 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 450 mg once weekly for 6 months
Number of subjects: 384
Study 9631991 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 450 mg once weekly for 9 months
Number of subjects: 384
Study 9631991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 384
Study 10150183 — intervention group
Group type: EXPERIMENTAL
Intervention: Trapidil (T) 100 mg t.i.d.
Number of subjects: 360
Study 10150183 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (ASA) 100 mg t.i.d.
Number of subjects: 360
Study 2566707 — intervention group
Group type: EXPERIMENTAL
Intervention: Carteolol 2% (20 eyes)
Number of subjects: 35
Study 2566707 — intervention group
Group type: EXPERIMENTAL
Intervention: Metipranolol 0.6% (20 eyes)
Number of subjects: 35
Study 2566707 — intervention group
Group type: COMPARATOR
Intervention: Oxybuprocain 0.4% (10 eyes)
Number of subjects: 35
Study 2566707 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9% (20 eyes)
Number of subjects: 35
Study 31087150 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency clamp (BRC)
Number of subjects: 50
Study 31087150 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma blade (PB)
Number of subjects: 50
Study 31087150 — intervention group
Group type: COMPARATOR
Intervention: Cold dissection (CD)
Number of subjects: 50
Study 27929203 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (0.08 mg/kg/day)
Number of subjects: 341
Study 27929203 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341
Study 25280140 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid flexible laryngoscope (RIFL)
Number of subjects: 41
Study 25280140 — intervention group
Group type: COMPARATOR
Intervention: Fiberoptic bronchoscope (FOB)
Number of subjects: 41
Study 23467248 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid stabilization using DIAM
Number of subjects: 75
Study 23467248 — intervention group
Group type: COMPARATOR
Intervention: PLIF
Number of subjects: 75
Study 21351082 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-ALA
Number of subjects: 370
Study 21351082 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 370
Study 19781044 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT) plus anterior repair
Number of subjects: 56
Study 19781044 — intervention group
Group type: COMPARATOR
Intervention: Colposuspension
Number of subjects: 56
Study 15880334 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan 30 mg/day
Number of subjects: 2260
Study 15880334 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 2260
Study 15152493 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy (low dose aspirin 75 to 150 mg)
Number of subjects: 0
Study 15152493 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 0
Study 15152493 — intervention group
Group type: COMPARATOR
Intervention: Aspirin plus clopidogrel
Number of subjects: 0
Study 15152493 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 0
Study 15152493 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study 15152493 — intervention group
Group type: EXPERIMENTAL
Intervention: Ximelagatran
Number of subjects: 0
Study 12579659 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% diclofenac sodium (DS) eyedrops
Number of subjects: 70
Study 12579659 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 70
Study 7601080 — intervention group
Group type: EXPERIMENTAL
Intervention: 200mg oral iodized oil
Number of subjects: 110
Study 7601080 — intervention group
Group type: EXPERIMENTAL
Intervention: 400mg oral iodized oil
Number of subjects: 110
Study 2564763 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam (15 mg)
Number of subjects: 52
Study 2564763 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam (15 mg)
Number of subjects: 52
Study 2564763 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg)
Number of subjects: 52
Study 2564763 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 70935 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (Cyklokapron)
Number of subjects: 17
Study 70935 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 31706292 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Early Supported Discharge (VESD)
Number of subjects: 0
Study 31706292 — intervention group
Group type: COMPARATOR
Intervention: Ordinary discharge routine (Control)
Number of subjects: 0
Study 28531241 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin sodium (40 mg/d)
Number of subjects: 2867
Study 28531241 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 2867
Study 26132941 — intervention group
Group type: EXPERIMENTAL
Intervention: Afamelanotide (16 mg subcutaneous implant every 60 days)
Number of subjects: 168
Study 23634822 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine (CAF01-adjuvanted HIV-1 peptides)
Number of subjects: 23
Study 23634822 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 20950305 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy performed (n=11,721)
Number of subjects: 50194
Study 20950305 — intervention group
Group type: EXPERIMENTAL
Intervention: No biopsy performed (n=1,238)
Number of subjects: 50194
Study 20950305 — intervention group
Group type: COMPARATOR
Intervention: Screening-positive men (biopsied and non-biopsied)
Number of subjects: 50194
Study 17614012 — intervention group
Group type: EXPERIMENTAL
Intervention: Loaded squat jumps
Number of subjects: 32
Study 17614012 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal voluntary isometric knee extension contractions (MVC)
Number of subjects: 32
Study 17614012 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG and antagonist co-activation during MVC
Number of subjects: 32
Study 17614012 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular efficiency during MVC
Number of subjects: 32
Study 17614012 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular efficiency during submaximal voluntary isometric knee extension contractions (MVC40)
Number of subjects: 32
Study 17614012 — intervention group
Group type: EXPERIMENTAL
Intervention: Agonist and antagonist activity during MVC
Number of subjects: 32
Study 17614012 — intervention group
Group type: EXPERIMENTAL
Intervention: MVC40
Number of subjects: 32
Study 17614012 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall strength and power
Number of subjects: 32
Study 16987435 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic product containing Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711
Number of subjects: 0
Study 16987435 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard yogurt containing Lactobacillus delbrueckii sp. bulgaricus
Number of subjects: 0
Study 16987435 — intervention group
Group type: COMPARATOR
Intervention: Dietary deprivation of fermented foods
Number of subjects: 0
Study 12779020 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole 500 mgs (OCT)
Number of subjects: 100
Study 12779020 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole 400 mgs (OCM)
Number of subjects: 100
Study 10968436 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatments
Number of subjects: 136
Study 10968436 — intervention group
Group type: COMPARATOR
Intervention: Standard treatments
Number of subjects: 136
Study 10968436 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-profit funded studies
Number of subjects: 136
Study 10968436 — intervention group
Group type: EXPERIMENTAL
Intervention: Profit-making funded studies
Number of subjects: 136
Study 9181163 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequestration of one unit of fresh autologous blood (5-8 ml/kg); Group I
Number of subjects: 42
Study 9181163 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequestration of two units of fresh autologous blood (12-15 ml/kg); Group II
Number of subjects: 42
Study 9181163 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group III)
Number of subjects: 42
Study 9181163 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume phlebotomy (Group II)
Number of subjects: 42
Study 9181163 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume phlebotomy (Group I)
Number of subjects: 42
Study 9181163 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 42
Study 1492432 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized coronary venous retroperfusion (SRP)
Number of subjects: 26
Study 1492432 — intervention group
Group type: COMPARATOR
Intervention: No SRP
Number of subjects: 26
Study 3903781 — intervention group
Group type: EXPERIMENTAL
Intervention: Factor XIII
Number of subjects: 25
Study 3903781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 29549016 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbert bone screw (HBS)
Number of subjects: 21
Study 29549016 — intervention group
Group type: EXPERIMENTAL
Intervention: Lag screw (LS)
Number of subjects: 21
Study 29549016 — intervention group
Group type: COMPARATOR
Intervention: Miniplate (MP)
Number of subjects: 21
Study 28451956 — intervention group
Group type: EXPERIMENTAL
Intervention: Short term psychodynamic psychotherapy (STPP)
Number of subjects: 47
Study 28451956 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic alliance as rated by patients
Number of subjects: 47
Study 28451956 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic alliance as rated by therapists
Number of subjects: 47
Study 25610916 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric toothbrush
Number of subjects: 72
Study 25610916 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual toothbrush + Persica mouthwash
Number of subjects: 72
Study 25610916 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual toothbrush + chlorhexidine mouthwash
Number of subjects: 72
Study 25610916 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 72
Study 22487908 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered endoscopic instruments
Number of subjects: 200